PT  - JOURNAL ARTICLE
AU  - Clarke, Bonnie N.
TI  - PET Radiopharmaceuticals: What’s New, What’s Reimbursed, and What’s Next?
AID  - 10.2967/jnmt.117.205021
DP  - 2018 Mar 01
TA  - Journal of Nuclear Medicine Technology
PG  - 12--16
VI  - 46
IP  - 1
4099  - http://tech.snmjournals.org/content/46/1/12.short
4100  - http://tech.snmjournals.org/content/46/1/12.full
SO  - J. Nucl. Med. Technol.2018 Mar 01; 46
AB  - The field of molecular imaging is undergoing a period of expansion. The number of radiopharmaceutical ligands, therapeutic isotope combinations, and targets continues to grow, with several new PET agents being approved over the last few years for diseases such as neuroendocrine tumor and prostate cancer. We will need to work together as a community to effectively use and advance these promising agents.